🇺🇸 FDA
Patent

US 11103581

Methods and compositions for self-regulated release of active pharmaceutical ingredient

granted A61KA61K31/5517A61K47/02

Quick answer

US patent 11103581 (Methods and compositions for self-regulated release of active pharmaceutical ingredient) held by Acurx Pharmaceuticals, Inc. expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Acurx Pharmaceuticals, Inc.
Grant date
Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/5517, A61K47/02, A61K47/12, A61K9/2027